Evidence map›Paper›PMID 21947281›Full record

ArticleMolecular and cellular biology2011

FOSL1 is integral to establishing the maternal-fetal interface.

Lindsey N Kent, M A Karim Rumi, Kaiyu Kubota, Dong-Soo Lee, Michael J Soares

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
4.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 72 citations in OpenAlex.

  1. Trial
  2. Article
  3. Super-Enhancers in Placental Development and Diseases.Journal of developmental biology · 2025
    Review
  4. KLF14 inhibits tumor progression via FOSL1 in glioma.Biochemistry and biophysics reports · 2025
    Article
  5. Article
  6. MicroRNAs: key regulators of the trophoblast function in pregnancy disorders.Journal of assisted reproduction and genetics · 2023
    Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. SUV39H2 controls trophoblast stem cell fate.Biochimica et biophysica acta. General subjects · 2021
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Accelerator or Brake: Immune Regulators in Malaria.Frontiers in cellular and infection microbiology · 2020
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Lindsey N KentInstitute for Reproductive Health and Regenerative Medicine, Department of Pathology & Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas 66160, USA.
M A Karim Rumi
Kaiyu Kubota
Dong-Soo Lee
Michael J Soares
Institute for Reproductive Health · USUniversity of Kansas Medical Center · US

Funding

TROPHOBLAST DIFFERENTIATIONR01HD020676 · NICHD · UNIVERSITY OF KANSAS MEDICAL CENTER · PI MICHAEL J SOARES · 1986 to 2026
$10.1M
NICHD NIH HHS HD20676NICHD NIH HHS R01 HD020676
6 · The paper itself

Abstract

Remodeling of uterine spiral arteries by trophoblast cells is a requisite process for hemochorial placentation and successful pregnancy. The rat exhibits deep intrauterine trophoblast invasion and accompanying trophoblast-directed vascular modification. The involvement of phosphatidylinositol 3 kinase (PI3K), AKT, and Fos-like antigen 1 (FOSL1) in regulating invasive trophoblast and hemochorial placentation was investigated using Rcho-1 trophoblast stem cells and rat models. Disruption of PI3K/AKT with small-molecule inhibitors interfered with the differentiation-dependent elaboration of a signature invasive-vascular remodeling trophoblast gene expression profile and trophoblast invasion. AKT isoform-specific knockdown also affected the signature invasive-vascular remodeling trophoblast gene expression profile. Nuclear FOSL1 increased during trophoblast cell differentiation in a PI3K/AKT-dependent manner. Knockdown of FOSL1 disrupted the expression of a subset of genes associated with the invasive-vascular remodeling trophoblast phenotype, including the matrix metallopeptidase 9 gene (Mmp9). FOSL1 was shown to occupy regions of the Mmp9 promoter in trophoblast cells critical for the regulation of Mmp9 gene expression. Inhibition of FOSL1 expression also abrogated trophoblast invasion, as assessed in vitro and following in vivo trophoblast-specific lentivirally delivered FOSL1 short hairpin RNA (shRNA). In summary, FOSL1 is a key downstream effector of the PI3K/AKT signaling pathway responsible for development of trophoblast lineages integral to establishing the maternal-fetal interface.

Indexed as

Maternal-Fetal ExchangeAnimalsCell DifferentiationCell LineCell MovementCricetinaeFemaleFos-Related Antigen 1Gene ExpressionGene Expression RegulationGene Knockdown TechniquesIsoenzymesMaleMatrix Metalloproteinase 9Phosphatidylinositol 3-KinasesPlacentaFos-Related Antigen 1IsoenzymesMatrix Metalloproteinase 9Phosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktProto-Oncogene Proteins c-fos

Identifiers

PMID21947281
PMCPMC3232930
OpenAlexW2155889218

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.